103 related articles for article (PubMed ID: 3346559)
1. Thioredoxin reductase activity in Hermansky-Pudlak syndrome: a method for identification of putative heterozygotes.
Schallreuter KU; Witkop CJ
J Invest Dermatol; 1988 Mar; 90(3):372-7. PubMed ID: 3346559
[TBL] [Abstract][Full Text] [Related]
2. Hermansky-Pudlak syndrome in a Swiss population.
Schallreuter KU; Frenk E; Wolfe LS; Witkop CJ; Wood JM
Dermatology; 1993; 187(4):248-56. PubMed ID: 8274781
[TBL] [Abstract][Full Text] [Related]
3. Regulation of thioredoxin reductase by calcium in Hermansky-Pudlak syndrome.
Schallreuter KU; Pittelkow MR
Arch Dermatol Res; 1989; 281(1):40-4. PubMed ID: 2730141
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin reductase. Role in free radical reduction in different hypopigmentation disorders.
Schallreuter KU; Hordinsky MK; Wood JM
Arch Dermatol; 1987 May; 123(5):615-9. PubMed ID: 3579341
[TBL] [Abstract][Full Text] [Related]
5. Albinism and Hermansky-Pudlak syndrome in Puerto Rico.
Witkop CJ; Nuñez Babcock M; Rao GH; Gaudier F; Summers CG; Shanahan F; Harmon KR; Townsend D; Sedano HO; King RA
Bol Asoc Med P R; 1990 Aug; 82(8):333-9. PubMed ID: 2261023
[TBL] [Abstract][Full Text] [Related]
6. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location.
King RA; Olds DP
Am J Med Genet; 1985 Jan; 20(1):49-55. PubMed ID: 3918447
[TBL] [Abstract][Full Text] [Related]
7. [Hermansky-Pudlak syndrome].
Schallreuter KU
Hautarzt; 1989 Mar; 40(3):130-3. PubMed ID: 2654078
[TBL] [Abstract][Full Text] [Related]
8. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
Schallreuter KU; Pittelkow MR
Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.
Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL
J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222
[TBL] [Abstract][Full Text] [Related]
10. Hermansky-Pudlak syndrome: an immunologic assessment of 15 cases.
Shanahan F; Randolph L; King R; Oseas R; Brogan M; Witkop C; Rotter J; Targan S
Am J Med; 1988 Dec; 85(6):823-8. PubMed ID: 3195606
[TBL] [Abstract][Full Text] [Related]
11. The Hermansky-Pudlak syndrome. Evidence for a lowered 5-hydroxytryptamine content in platelets of heterozygotes.
Gerritsen SM; Akkerman JW; Nijmeijer B; Sixma JJ; Witkop CJ; White J
Scand J Haematol; 1977 Mar; 18(3):249-56. PubMed ID: 847398
[TBL] [Abstract][Full Text] [Related]
12. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome).
Gahl WA; Brantly M; Kaiser-Kupfer MI; Iwata F; Hazelwood S; Shotelersuk V; Duffy LF; Kuehl EM; Troendle J; Bernardini I
N Engl J Med; 1998 Apr; 338(18):1258-64. PubMed ID: 9562579
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin reductase activity at the surface of human primary cutaneous melanomas and their surrounding skin.
Schallreuter KU; Jänner M; Mensing H; Breitbart EW; Berger J; Wood JM
Int J Cancer; 1991 Apr; 48(1):15-9. PubMed ID: 2019454
[TBL] [Abstract][Full Text] [Related]
14. Hermansky-Pudlak syndrome. Pulmonary manifestations of a ceroid storage disorder.
Garay SM; Gardella JE; Fazzini EP; Goldring RM
Am J Med; 1979 May; 66(5):737-47. PubMed ID: 443250
[TBL] [Abstract][Full Text] [Related]
15. The melanin pigmentary disorder in a family with Hermansky-Pudlak syndrome.
Frenk E; Lattion F
J Invest Dermatol; 1982 Feb; 78(2):141-3. PubMed ID: 7057049
[TBL] [Abstract][Full Text] [Related]
16. A clinical variant of familial Hermansky-Pudlak syndrome.
Iannello S; Fabbri G; Bosco P; Cavaleri A; Cantarella S; Camuto M; Milazzo P; Romeo F; Belfiore F
MedGenMed; 2003 Jan; 5(1):3. PubMed ID: 12827064
[TBL] [Abstract][Full Text] [Related]
17. Perturbed epidermal pterin metabolism in Hermansky-Pudlak syndrome.
Schallreuter KU; Beazley WD; Hibberts NA; Swanson NN; Pittelkow MR
J Invest Dermatol; 1998 Sep; 111(3):511-6. PubMed ID: 9740249
[TBL] [Abstract][Full Text] [Related]
18. An immunochemical method for determining thioredoxin reductase in rat tissues.
Chen CC; Moore EC
Anal Biochem; 1977 Dec; 83(2):609-14. PubMed ID: 414635
[No Abstract] [Full Text] [Related]
19. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene.
Toro J; Turner M; Gahl WA
Arch Dermatol; 1999 Jul; 135(7):774-80. PubMed ID: 10411151
[TBL] [Abstract][Full Text] [Related]
20. Hermansky-Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non-Puerto Rican cases.
Hermos CR; Huizing M; Kaiser-Kupfer MI; Gahl WA
Hum Mutat; 2002 Dec; 20(6):482. PubMed ID: 12442288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
